BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8566127)

  • 1. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats.
    Medeiros MV; Binhara IM; Moreno Júnior H; Zatz R; De Nucci G; Antunes E
    Eur J Pharmacol; 1995 Oct; 285(2):109-14. PubMed ID: 8566127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis.
    Ferreira HH; Medeiros MV; Lima CS; Flores CA; Sannomiya P; Autunes E; De Nucci G
    Eur J Pharmacol; 1996 Aug; 310(2-3):201-7. PubMed ID: 8884218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of acute inflammation by endogenous nitric oxide.
    Ialenti A; Ianaro A; Moncada S; Di Rosa M
    Eur J Pharmacol; 1992 Feb; 211(2):177-82. PubMed ID: 1612108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
    Honoré P; Chapman V; Buritova J; Besson JM
    Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageenin-soaked sponge implants in rat.
    Iuvone T; Van Osselaer N; D'Acquisto F; Carnuccio R; Herman AG
    Br J Pharmacol; 1997 Aug; 121(8):1637-44. PubMed ID: 9283697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.
    Filep JG; Földes-Filep E; Rousseau A; Sirois P; Fournier A
    Br J Pharmacol; 1993 Nov; 110(3):1213-21. PubMed ID: 8298811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation by nitric oxide of prostaglandin biosynthesis in the rat.
    Sautebin L; Ialenti A; Ianaro A; Di Rosa M
    Br J Pharmacol; 1995 Jan; 114(2):323-8. PubMed ID: 7533614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema.
    Sautebin L; Ialenti A; Ianaro A; Di Rosa M
    Eur J Pharmacol; 1995 Nov; 286(2):219-22. PubMed ID: 8605961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin.
    Lippe IT; Stabentheiner A; Holzer P
    Eur J Pharmacol; 1993 Feb; 232(1):113-20. PubMed ID: 7681404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
    Bryant CE; Allcock GH; Warner TD
    Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease.
    Moreno H; Metze K; Bento AC; Antunes E; Zatz R; de Nucci G
    Basic Res Cardiol; 1996; 91(3):248-55. PubMed ID: 8831944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide modulates the development and surgical reversal of renovascular hypertension in rats.
    Huang WC; Tsai RY; Fang TC
    J Hypertens; 2000 May; 18(5):601-13. PubMed ID: 10826564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis.
    Erley CM; Rebmann S; Strobel U; Schmidt T; Wehrmann M; Osswald H; Risler T
    Exp Nephrol; 1995; 3(5):293-9. PubMed ID: 7583051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
    Orucevic A; Lala PK
    Br J Cancer; 1996 Jan; 73(2):189-96. PubMed ID: 8546905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between nitric oxide and prostaglandins in carrageenin pleurisy.
    Sautebin L; Ialenti A; Ianaro A; Di Rosa M
    Biochem Pharmacol; 1998 Apr; 55(7):1113-7. PubMed ID: 9605435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.